Trial Outcomes & Findings for Ability of Four Toothpastes to Remove Plaque (NCT NCT03285984)
NCT ID: NCT03285984
Last Updated: 2018-10-16
Results Overview
The dental examiner used Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth.Overall plaque scores were calculated taking average over all tooth sites for participant.Plaque was first disclosed using dye solution followed by disclosing solution.They expectorated and rinsed with 10 milliliters (mL) water for 10 seconds (sec),expectorated again. Plaque was assessed with each tooth being divided into 6 areas including mesiofacial,facial,distofacial,mesiolingual,lingual,distolingual surfaces.Disclosed plaque was scored for each tooth surface separately as:0 No plaque;1 Slight flecks of plaque at cervical margin of the tooth;2 A thin continuous band of plaque(1 mm or smaller) at cervical margin of tooth;3 A band of plaque wider than 1 mm but covering less than 1/3 of the crown of tooth;4 Plaque covering at least 1/3 but less than 2/3 of crown of tooth;5 Plaque covering 2/3 or more of crown of tooth.Score range 0-5.Lower scores indicate less plaque area.
COMPLETED
NA
56 participants
Baseline to 4 Weeks
2018-10-16
Participant Flow
Participants were recruited at a single center in the United States.
A Total of 56 participants were screened and randomized in the study. All 56 participants completed the study.
Participant milestones
| Measure |
Overall Study
This was a single centre, randomized, controlled, examiner blind, four treatment, four period crossover design study. Each Participant received Test product 1 (Toothpaste containing 67 percent \[%\] sodium bicarbonate with 6 herbs plus 923 parts per million \[ppm\] sodium fluoride, Test product 2 (Toothpaste containing 67% sodium bicarbonate without herbs plus 923ppm sodium fluoride), Test product 3 (Whitening Toothpaste containing 62% Sodium Bicarbonate with 6 herbs and 5% weight by weight \[w/w\] silica plus 923ppm Sodium), and Test product 4 (Toothpaste containing 0% Sodium Bicarbonate without herbs plus 923ppm sodium fluoride).
|
|---|---|
|
Overall Study
STARTED
|
56
|
|
Overall Study
Received Test Product 1
|
56
|
|
Overall Study
Received Test Product 2
|
56
|
|
Overall Study
Received Test Product 3
|
56
|
|
Overall Study
Received Test Product 4
|
56
|
|
Overall Study
COMPLETED
|
56
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Ability of Four Toothpastes to Remove Plaque
Baseline characteristics by cohort
| Measure |
All Randomized Participants
n=56 Participants
All randomized participants were included for baseline evaluation.
|
|---|---|
|
Age, Continuous
|
44.1 Years
STANDARD_DEVIATION 11.87 • n=5 Participants
|
|
Sex: Female, Male
Female
|
36 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
20 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
5 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
51 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline to 4 WeeksPopulation: ITT (Intent-to-treat) population was the primary analysis population, which included all the participants who were randomized and had at least one post-baseline efficacy evaluation.
The dental examiner used Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth.Overall plaque scores were calculated taking average over all tooth sites for participant.Plaque was first disclosed using dye solution followed by disclosing solution.They expectorated and rinsed with 10 milliliters (mL) water for 10 seconds (sec),expectorated again. Plaque was assessed with each tooth being divided into 6 areas including mesiofacial,facial,distofacial,mesiolingual,lingual,distolingual surfaces.Disclosed plaque was scored for each tooth surface separately as:0 No plaque;1 Slight flecks of plaque at cervical margin of the tooth;2 A thin continuous band of plaque(1 mm or smaller) at cervical margin of tooth;3 A band of plaque wider than 1 mm but covering less than 1/3 of the crown of tooth;4 Plaque covering at least 1/3 but less than 2/3 of crown of tooth;5 Plaque covering 2/3 or more of crown of tooth.Score range 0-5.Lower scores indicate less plaque area.
Outcome measures
| Measure |
Test Product 1
n=56 Participants
Participants brushed once (1.5g ± 0.05g of toothpaste containing 67 % sodium bicarbonate with 6 herbs plus 923 ppm sodium fluoride), under supervision of study staff for one timed minute.
|
Test Product 4
n=56 Participants
Participants brushed once (1.5g ± 0.05g of toothpaste containing 0% Sodium Bicarbonate without herbs plus 923ppm sodium fluoride), under supervision of study staff for one timed minute.
|
Test Product 3
Participants brushed once (1.5g ± 0.05g of whitening toothpaste containing 62% Sodium Bicarbonate with 6 herbs and 5% w/w silica plus 923ppm Sodium), under supervision of study staff for one timed minute.
|
Test Product 4
Participants brushed once (1.5g ± 0.05g of toothpaste containing 0% Sodium Bicarbonate without herbs plus 923ppm sodium fluoride), under supervision of study staff for one timed minute.
|
|---|---|---|---|---|
|
Mean Change From Baseline (Pre-brushing to Post-brushing) in Turesky Score After Single Supervised Use (Test Product 1 Versus [vs] Test Product 4) After 4 Weeks
Baseline
|
2.90 Score on a scale
Standard Deviation 0.308
|
2.86 Score on a scale
Standard Deviation 0.309
|
—
|
—
|
|
Mean Change From Baseline (Pre-brushing to Post-brushing) in Turesky Score After Single Supervised Use (Test Product 1 Versus [vs] Test Product 4) After 4 Weeks
Post Baseline
|
1.76 Score on a scale
Standard Deviation 0.514
|
1.96 Score on a scale
Standard Deviation 0.470
|
—
|
—
|
|
Mean Change From Baseline (Pre-brushing to Post-brushing) in Turesky Score After Single Supervised Use (Test Product 1 Versus [vs] Test Product 4) After 4 Weeks
Change from Baseline
|
-1.13 Score on a scale
Standard Deviation 0.430
|
-0.90 Score on a scale
Standard Deviation 0.409
|
—
|
—
|
SECONDARY outcome
Timeframe: Baseline to 4 WeeksPopulation: ITT (Intent-to-treat) population was the primary analysis population, which included all the participants who were randomized and had at least one post-baseline efficacy evaluation.
The dental examiner used Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth.Overall plaque scores were calculated taking average over all tooth sites for participant.Plaque was first disclosed using dye solution followed by disclosing solution.They expectorated and rinsed with 10 mL of water for 10 sec,expectorated again. Plaque was assessed with each tooth being divided into 6 areas including mesiofacial,facial,distofacial,mesiolingual,lingual,distolingual surfaces.Disclosed plaque was scored for each tooth surface separately as:0 No plaque;1 Slight flecks of plaque at cervical margin of the tooth;2 A thin continuous band of plaque(1 mm or smaller) at cervical margin of tooth;3 A band of plaque wider than 1 mm but covering less than 1/3 of the crown of tooth;4 Plaque covering at least 1/3 but less than 2/3 of crown of tooth;5 Plaque covering 2/3 or more of crown of tooth.Score range 0-5.Lower scores indicate less plaque area.
Outcome measures
| Measure |
Test Product 1
n=56 Participants
Participants brushed once (1.5g ± 0.05g of toothpaste containing 67 % sodium bicarbonate with 6 herbs plus 923 ppm sodium fluoride), under supervision of study staff for one timed minute.
|
Test Product 4
n=56 Participants
Participants brushed once (1.5g ± 0.05g of toothpaste containing 0% Sodium Bicarbonate without herbs plus 923ppm sodium fluoride), under supervision of study staff for one timed minute.
|
Test Product 3
n=56 Participants
Participants brushed once (1.5g ± 0.05g of whitening toothpaste containing 62% Sodium Bicarbonate with 6 herbs and 5% w/w silica plus 923ppm Sodium), under supervision of study staff for one timed minute.
|
Test Product 4
n=56 Participants
Participants brushed once (1.5g ± 0.05g of toothpaste containing 0% Sodium Bicarbonate without herbs plus 923ppm sodium fluoride), under supervision of study staff for one timed minute.
|
|---|---|---|---|---|
|
Mean Change From Baseline (Pre-brushing to Post Brushing) in Turesky Score After Single Supervised Use for Test Products 1, 2, 3 and 4 After 4 Weeks
Baseline
|
2.90 Score on a scale
Standard Deviation 0.308
|
2.92 Score on a scale
Standard Deviation 0.312
|
2.89 Score on a scale
Standard Deviation 0.304
|
2.86 Score on a scale
Standard Deviation 0.309
|
|
Mean Change From Baseline (Pre-brushing to Post Brushing) in Turesky Score After Single Supervised Use for Test Products 1, 2, 3 and 4 After 4 Weeks
Post Baseline
|
1.76 Score on a scale
Standard Deviation 0.514
|
1.78 Score on a scale
Standard Deviation 0.492
|
1.77 Score on a scale
Standard Deviation 0.469
|
1.96 Score on a scale
Standard Deviation 0.470
|
|
Mean Change From Baseline (Pre-brushing to Post Brushing) in Turesky Score After Single Supervised Use for Test Products 1, 2, 3 and 4 After 4 Weeks
Change from Baseline after 4 weeks
|
-1.13 Score on a scale
Standard Deviation 0.430
|
-1.14 Score on a scale
Standard Deviation 0.426
|
-1.11 Score on a scale
Standard Deviation 0.419
|
-0.90 Score on a scale
Standard Deviation 0.409
|
Adverse Events
Test Product 1
Test Product 2
Test Product 3
Test Product 4
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
- Publication restrictions are in place
Restriction type: OTHER